唯捷創芯(688153.SH):未來公司將繼續在AI玩具等物聯網領域進行佈局
格隆匯7月7日丨唯捷創芯(688153.SH)在互動平臺表示,作爲星閃聯盟的成員,公司一直積極參與相關標準的制定和產品研發,已有射頻前端產品支持星閃(SLE)技術標準。針對AI玩具等物聯網領域的射頻功率放大器需求,公司已與AI端側廠商深度對接,瞭解特殊需求,並據此開發相關產品。目前,公司首款同時支持藍牙和星閃的模組產品已在客戶端推廣,未來公司將繼續在AI玩具等物聯網領域進行佈局,以滿足市場對高性能射頻前端產品的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.